NEW YORK, Nov. 24, 2014 /PRNewswire/ -- About Prostate Cancer
Prostate cancer initiates in the prostate, which is an exocrine gland present in the male reproductive system. The main function of the prostate is to make fluid for semen. The risk of developing prostate cancer is age dependent. Prostate cancer affects mostly men over the age of 65 and rarely occurs in men younger than 40 years of age.
TechNavio's analysts forecast the Global Prostate Cancer Drugs market to grow at a CAGR of 10.45 percent over the period 2013-2018.
Covered in this Report
The Global Prostate Cancer Drugs market can be divided into four segments: Hormonal Therapy, Chemo Therapy, Immuno Therapy and Targeted Therapy. This report covers the present scenario and the growth prospects of the Global Prostate Cancer Drugs market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the form of hormonal therapy, chemo therapy, immuno therapy, and targeted therapy for prostate cancer that are available in the market.
TechNavio's report, the Global Prostate Cancer Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Prostate Cancer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbvie
• Astra Zeneca
• Janssen Pharmaceuticals
• Sanofi
Other Prominent Vendors
• Amgen
• Astellas Pharma
• Bayer
• BMS
• Dendreon
• Endo Pharmaceuticals
• Ferring Pharmaceutical
• F. Hoffmann-La Roche
• GSK
• Ipsen
• Medivation
• Merck
• Novartis
• Pfizer
• Teva Pharmaceuticals
Market Driver
• Increase in Global Aging Population
• For a full, detailed list, view our report
Market Challenge
• High Cost of Prostate Cancer Drugs
• For a full, detailed list, view our report
Market Trend
• Major Opportunities for Pharmaceutical Companies
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Read the full report: http://www.reportlinker.com/p02464358-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-prostate-cancer-drugs-market-2014-2018-300000540.html
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article